Year in Review: Top 20 medicines by gross cost

Rank Medicine Gross cost
1 Glecaprevir and pibrentasvir (Maviret) 106,920,000
2 Adalimumab 89,090,000
3 Dabigatran 43,930,000
4 Trastuzumab 37,300,000
5 Pembrolizumab 33,400,000
6 Insulin glargine 31,380,000
7 Paritaprevir with ritonavir and ombitasvir copackaged with dasabuvir 30,870,000
8 Etanercept 30,310,000
9 Pneumococcal (PCV10) conjugate vaccine 30,230,000
10 Fluticasone with salmeterol 25,070,000
11 Abiraterone 24,770,000
12 Lenalidomide 22,280,000
13 Human papillomavirus vaccine 21,500,000
14 Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type B vaccine 21,110,000
15 Budesonide with eformoterol 20,540,000
16 Rituximab 20,340,000
17 Varicella zoster virus vaccine (shingles vaccine) 14,690,000
18 Bortezomib 14,060,000
19 Paliperidone 13,990,000
20 Dolutegravir 13,270,000

 

< Top 20 medicine groups by prescription volume | Measuring our impact >